🏥 Health
6d ago
'Grand Slam' in Pancreatic Cancer: Novel Pill Doubles Survival
Source ↗
👁 3
💬 0
(MedPage Today) -- CHICAGO -- RASolute 302 trial results were hailed as a game-changing breakthrough in the treatment of pancreatic cancer.
The phase III study showed that second-line daraxonrasib, an investigational oral RAS(ON) multi-selective...
The phase III study showed that second-line daraxonrasib, an investigational oral RAS(ON) multi-selective...
Comments (0)